InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Lindborg Stacy. Officer active across 2 companies, notably Brainstorm Cell Therapeutics INC.. Aggregated, 14 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €41k. Activity tracked since 7 December 2022. The latest transaction was filed on 28 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Lindborg Stacy is a declarant associated with Imunon, Inc. and Brainstorm Cell Therapeutics INC., with the listed roles of President and CEO at Imunon, Inc. and Director at Brainstorm Cell Therapeutics INC. The total number of filings is 12, and among the sampled recent filings from 2023-01-04 to 2026-08-04, buys total 41142 EUR and sells total 0 EUR, with the modal transaction nature listed as Attribution.